Oosterveer, Timo T. M.
van Erp, Gonnie C. M.
Hendriks, Pim
Broersen, Alexander
Overduin, Christiaan G.
van Rijswijk, Carla S. P.
van Erkel, Arian R.
van der Meer, Rutger W.
Tushuizen, Maarten E.
Moelker, Adriaan
Meijerink, Martijn R.
van Delden, Otto M.
de Jong, Koert P.
van der Leij, Christiaan
Smits, Maarten L. J.
Urlings, Thijs A. J.
Braak, Jeffrey P. B. M.
Meershoek-Klein Kranenbarg, Elma
van Duijn-de Vreugd, Bianca
Zeijdner, Evelijn
Goeman, Jelle J.
Fütterer, Jurgen J.
Coenraad, Minneke J.
Dijkstra, Jouke
Burgmans, Mark C.
Funding for this research was provided by:
KWF Kankerbestrijding (12879)
Article History
Received: 23 September 2021
Accepted: 27 January 2022
First Online: 1 March 2022
Declarations
:
: M.C. Burgmans has received a speaker honorarium and a research grant from Medtronic, and an educational grant from Boston Scientific. None are related to the current project. J.J. Fütterer is advisory board member at NDR and is participating in the NOLA study from J&J. None are related to the current project. All other authors declare that they have no conflict of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Approval of this study was provided by the Medical Ethics Committee Leiden-Den Haag-Delft (NL75744.058.21).
: For this type of study consent for publication is not required.
: Informed consent will be obtained from all individual participants included in the study.